Investment Rating - The report gives a "Buy" rating for the company, Saint Bella Group [3][11]. Core Insights - Saint Bella Group is the leading high-end postpartum care and recovery group in Asia and China, leveraging a light asset model for rapid expansion and focusing on service standardization, specialization, customization, and digital upgrades [1][21]. - Despite a decline in the total number of newborns in China, the postpartum care industry has structural growth potential driven by the increasing willingness of affluent families to have children and the rising demand for professional postpartum care [1][11]. - The company is positioned to benefit from the dual trends of upgraded fertility consumption and accelerated industry consolidation, with head brands expected to gain market share through enhanced service experiences and operational efficiencies [1][11]. Summary by Sections Company Overview - Saint Bella Group operates a brand matrix covering various postpartum care services, including postpartum recovery and family care, with a focus on high-net-worth clients [21][25]. - The company has established 113 postpartum care centers globally, including in mainland China, Hong Kong, Singapore, and the United States, with plans for further international expansion [21][29]. Industry Analysis - The postpartum care industry in China is transitioning from quantity-driven growth to quality-driven growth, with a focus on high-income families who have a higher birth rate [2][11]. - The demand for postpartum care services is becoming increasingly essential, driven by changing perceptions and the need for quality care [2][11]. Competitive Advantages - The company utilizes a low-trust cost and efficient customer acquisition strategy through partnerships with high-end hotels and leveraging celebrity endorsements [2][3]. - A digital ecosystem centered around the Doctor Bella platform enhances customer experience and supports expansion efforts [2][3]. - The company has built a standardized operational system to ensure service quality and operational efficiency, facilitating scalable growth [2][3]. Financial Projections - The adjusted net profit for the company is projected to reach 1.21 billion, 1.78 billion, and 2.79 billion yuan for the years 2025 to 2027, with corresponding adjusted EPS of 0.19, 0.29, and 0.45 yuan [3][4]. - Revenue is expected to grow significantly, with a forecasted increase from 560 million yuan in 2023 to 1.62 billion yuan in 2027, reflecting a compound annual growth rate [4][11]. Investment Thesis - The company is well-positioned to capitalize on the structural upgrades in the postpartum care industry and the growing demand for high-quality services, particularly among affluent families [11][21]. - The expansion into overseas markets and the diversification of service offerings are expected to further enhance revenue potential and market presence [11][21].

Investment Rating - The report gives a "Buy" rating for the company, with a target price of HKD 9.73 based on a 27X valuation for 2026 [4]. Core Insights - The company, Saint Bella, is a leading global family care brand group, focusing on high-end postpartum care centers, family care services, and women's health foods, with plans to expand its store network significantly by 2025 [1][14]. - The postpartum care and recovery industry in China is projected to reach a market size of RMB 67.5 billion in 2024, indicating substantial growth potential and a shift towards premium services [2][37]. - The company has demonstrated strong financial performance, with a revenue of RMB 450 million in the first half of 2025, reflecting a year-on-year growth of 25.64%, and an adjusted net profit of RMB 39 million, up 126% [1][4]. Summary by Sections Company Overview - Saint Bella operates a multi-brand strategy with three main brands: "Saint Bella" for high-net-worth families, "Ai Yu" focusing on women's mental health, and "Little Bella" targeting younger markets [1][17]. - The company has expanded its presence internationally, with plans to double its store count in mainland China by 2030 and enter key global cities [3][14]. Industry Analysis - The postpartum care and recovery market is characterized by low penetration rates, suggesting significant room for growth and premiumization [2][37]. - The overall family care industry in China is expected to grow from RMB 392.8 billion in 2019 to RMB 805.3 billion by 2025, with a CAGR of 12.4% [37]. Competitive Advantages - The company leverages a light-asset model for rapid store expansion and has established a standardized care system supported by a team of leading experts [2][3]. - Its multi-brand strategy allows for clear brand positioning and different channel expansion paths, enhancing customer acquisition efficiency [2][3]. Future Development - The company aims to extend its service offerings to include postpartum recovery, family care, and elderly care, thereby maximizing customer lifetime value [3][4]. - Saint Bella is also focusing on integrating AI into its services, aiming to transform the traditional maternal and infant care industry [3][4]. Financial Projections - The company anticipates adjusted net profits of RMB 120 million, RMB 200 million, and RMB 298 million for 2025, 2026, and 2027, respectively, reflecting significant growth rates [4][5]. - Revenue is projected to reach RMB 1.85 billion by 2027, with a consistent growth trajectory across its business segments [5][20].

Investment Rating - The report assigns a "Buy" rating to the company with a target price of HKD 9.73 based on a 27X valuation for 2026 [4]. Core Insights - The company, Saint Bella, is a leading global family care brand group, focusing on high-end postpartum care centers, family care services, and women's health foods, with plans to expand its store network significantly by 2025 [1][3]. - The postpartum care and recovery industry in China is projected to reach a market size of RMB 67.5 billion in 2024, indicating substantial growth potential and a shift towards premium services [2][37]. - The company has demonstrated strong financial performance, with a revenue of RMB 450 million in the first half of 2025, reflecting a year-on-year growth of 25.64%, and an adjusted net profit of RMB 39 million, up 126% year-on-year [1][4]. Summary by Sections Company Overview - Saint Bella operates a multi-brand strategy with three main brands: "Saint Bella" for high-net-worth families, "Ai Yu" focusing on women's mental health, and "Little Bella" targeting younger markets [1][17]. - The company has expanded its presence internationally, with plans to double its store count in mainland China by 2030 and enter key global cities [3][14]. Industry Analysis - The postpartum care and recovery market is characterized by low penetration rates, indicating significant growth opportunities [2][37]. - The overall family care industry in China is expected to grow from RMB 392.8 billion in 2019 to RMB 805.3 billion by 2025, with a CAGR of 12.6% [37]. Competitive Advantages - The company leverages a light-asset model for rapid store expansion and has established a standardized care system supported by a team of leading experts [2][3]. - Its multi-brand strategy allows for clear brand positioning and different channel expansion paths, enhancing customer acquisition efficiency [2][3]. Future Development - The company aims to integrate AI into its services, targeting the trillion-dollar AI application market in the family care sector [3][4]. - Plans include expanding postpartum recovery and family care services to capture the full lifecycle value of customers [3][4]. Financial Projections - The company anticipates adjusted net profits of RMB 120 million, RMB 200 million, and RMB 298 million for 2025, 2026, and 2027, respectively, reflecting significant growth rates [4][5]. - Revenue is projected to reach RMB 1.85 billion by 2027, with a compound annual growth rate (CAGR) of 32.1% from 2025 to 2027 [5][4].

Core Viewpoint - The stock price of Saint Bella (02508.HK), known as the "Hermès of postpartum care," has been consistently below its IPO price, reflecting ongoing challenges in the high-end maternity care market despite initial capital support and a recent shift towards profitability [1][2][6]. Group 1: Company Background - Saint Bella was founded in 2017 by entrepreneurs Xianghua and Lin Wanyi, targeting a gap in the high-end maternity care market in China, particularly after the "two-child" policy was implemented [2][3]. - The company has received significant backing from notable investors, including Tencent and other prominent institutions, completing 10 rounds of financing before its IPO [3][4]. Group 2: Financial Performance - From 2021 to 2024, Saint Bella reported revenues of 259 million, 472 million, 560 million, and 799 million yuan, respectively, while incurring cumulative losses of 1.19 billion, 4.07 billion, 2.39 billion, and 5.47 billion yuan [8]. - In the first half of 2025, the company achieved a net profit of 327 million yuan, largely due to a 318 million yuan gain from the fair value change of financial instruments issued to investors [8]. Group 3: Market Position and Services - Saint Bella operates 113 stores globally as of August 2025, offering high-end postpartum care services through its brands, including Saint Bella, Aiyu, and Xiaobella, catering to different market segments [6][8]. - The company is recognized for its premium pricing, with packages reaching up to 1.048 million yuan for a 56-day stay, attracting high-profile clients such as celebrities [7][8]. Group 4: Strategic Initiatives - Saint Bella is actively expanding internationally, having entered the U.S. market with locations in California and New York, and is leveraging AI technology to enhance its service offerings [8][9]. - The company has implemented a "partner store plan," which has significantly increased the number of managed maternity centers, contributing to a 159.6% year-on-year revenue growth from these locations [8].

Group 1 - The industry is entering a reshuffling phase, with Shengbeila (02508) establishing a special regulatory account with banks to enhance service standards and operational thresholds, which is expected to accelerate supply clearance [1][2] - Shengbeila is likely to benefit from a light asset model relying on hotels and a strategy of initially managing before acquiring, with adjusted net profit forecasts for 2025-2027 at 1.21 billion, 1.98 billion, and 3.02 billion yuan respectively [1] - The current stock price corresponds to a PE valuation of 32x, 19x, and 13x for the respective years, maintaining a "buy" rating with a target price of 10.36 HKD based on a 30x target PE for 2026 [1] Group 2 - As an industry leader, the company is the first to implement independent bank custody and closed fund supervision for customer prepayments, setting a benchmark for safety in the industry and promoting standardized development [2] - The industry is experiencing a wave of closures and bankruptcies, with notable cases such as Aijia Maternity Center, which filed for bankruptcy in early 2025, indicating a backlash from previous low-quality expansion and price wars [2] - The company's efforts to raise service standards and operational thresholds may accelerate supply clearance, positioning it to fully benefit as a standardized provider of high-quality products and services [2]

Group 1 - The industry is entering a reshuffling phase, with Shengbeila (02508) establishing a special regulatory account with banks to enhance service standards and operational thresholds, which is expected to accelerate supply clearance [1][2] - Shengbeila is anticipated to benefit from a light asset model reliant on hotels and a strategy of initially managing contracts before acquiring [1] - The adjusted net profit forecast for Shengbeila for 2025-2027 is projected at 1.21 billion, 1.98 billion, and 3.02 billion respectively, with a current PE valuation of 32x, 19x, and 13x, maintaining a "buy" rating and a target price of 10.36 HKD based on a 30x target PE for 2026 [1] Group 2 - As an industry leader, Shengbeila is the first to implement independent bank custody and closed-loop fund supervision for customer prepayments, setting a benchmark for industry safety and promoting standardized development [2] - The industry is experiencing a wave of closures and bankruptcies, with notable cases such as Aijia Maternity Center, which had 67 stores and went bankrupt in early 2025, indicating a backlash from previous low-quality expansion and price wars [2] - Shengbeila's efforts to raise service standards and operational thresholds are expected to accelerate supply clearance, positioning the company to fully benefit as a standardized provider of high-quality products and services [2]

Core Viewpoint - CITIC Securities initiates coverage on Saint Bella (02508) with a "Buy" rating, highlighting its position as the largest family care group in China and its potential for growth in the high-end maternity center market [1] Company Overview - Saint Bella operates several brands including Saint Bella, Little Bella, and Ai Yu, focusing on high-tier cities in China while gradually expanding globally [1] - The company holds the top market share in the family care industry, benefiting from the trend of smaller family structures and increasing self-care demands among women [1] Growth Potential - The report emphasizes that Saint Bella's luxury brand positioning, standardized professional services, and diverse brand matrix provide significant growth potential [1] - Single-store revenue is expected to increase, with clear opportunities for domestic and international store openings, driving both revenue and profit growth [1] Business Development - Family care services and food retail businesses have shown positive growth trends in recent years, which may further enhance the company's growth potential through synergies with maternity centers [1]

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company achieved a revenue of 450 million and a net profit of 327 million in the first half of 2025, reflecting a year-on-year growth of 25.64% and a turnaround from losses, with adjusted net profit increasing by 126.1% [5] - The company's gross margin and net margin for H1 2025 were 37.62% and 72.72%, respectively, showing improvements of 3.59 percentage points and 206.85 percentage points year-on-year [5] - The company has expanded its store network significantly, with a total of 113 stores globally as of June 30, 2025, including 31 self-operated and 53 managed postpartum centers [6] - The postpartum recovery and family care business segments are experiencing rapid growth, with self-operated centers generating 387 million in revenue, up 25.3% year-on-year, and managed centers achieving 73 million, a 159.6% increase [6] - The company is also expanding its overseas presence, having opened its first store in New York post-IPO, with plans for further international expansion [6] Financial Summary - The company forecasts revenues of 1.076 billion, 1.403 billion, and 1.777 billion for 2025, 2026, and 2027, respectively, representing year-on-year growth rates of 34.73%, 30.42%, and 26.65% [9] - The projected net profit for the same years is 315 million, 406 million, and 478 million, with growth rates of 157.65%, 28.75%, and 17.71% [9] - Adjusted net profit estimates for 2025, 2026, and 2027 are 122 million, 197 million, and 267 million, reflecting substantial growth of 189.63%, 61.58%, and 35.69% [9]

Core Viewpoint - The company reported strong financial performance in the first half of 2025, with significant revenue and profit growth, driven by effective management strategies and expansion of service offerings [1][2][3] Financial Performance - Revenue for the first half of 2025 reached 450 million, a year-on-year increase of 25.6%, while total revenue including the management center was 523 million, up 35% [1] - Adjusted net profit was 38.78 million, reflecting a 126.1% year-on-year increase, and net profit attributable to shareholders was 327 million, marking a turnaround from losses [1] - The company exceeded its previous profit forecast, with net profit not less than 320 million and adjusted net profit not less than 38 million [1] Business Expansion - The company accelerated its expansion, adding 36 new stores in the first half of 2025, surpassing the total number of new stores opened in 2024 [1][2] - The number of maternity centers reached 113 by the end of the first half of 2025, with significant contributions from various brands [2] Service Offerings and Growth - The company is developing a comprehensive service matrix, with new business segments such as postpartum recovery, home care, and food services showing positive growth trends [1][2] - The conversion rate for secondary sales reached a record high of 93.8%, indicating strong customer retention and cross-selling potential [2] Profitability and Efficiency - The gross margin for the maternity center business improved to 35.5%, up 3.5 percentage points year-on-year, benefiting from increased management output [2] - Marketing expenses decreased to 12.0% of revenue, and management expenses fell to 22.1%, contributing to an overall gross margin of 37.6% [3] Future Outlook - The company plans to launch the industry's first AI Agent product in the second half of 2025, which is expected to enhance profitability [3] - Long-term growth is anticipated through overseas expansion, mergers and acquisitions, and technological advancements [3] Earnings Forecast and Valuation - The company maintains its earnings forecast, projecting adjusted net profits of 121 million, 205 million, and 306 million for 2025 to 2027, respectively [3] - The target price is set at 9.76 HKD, with a "buy" rating based on the company's growth potential and market position [3]

Core Viewpoint - Saint Bella Limited has successfully diversified its service and product offerings, moving beyond traditional postpartum care centers to create a "second growth curve" through service extension and leveraging AI technology for cost reduction [1] Financial Performance - For the first half of 2025, Saint Bella reported revenue of 450 million yuan, a year-on-year increase of 25.6%; gross profit of 169 million yuan, up 38.9%; and a net profit attributable to shareholders of 327 million yuan, marking a return to profitability [1] - Basic earnings per share were 17.31 yuan [1] Business Segments - Saint Bella operates three main business lines: postpartum care centers, home care services, and food products [2] - The postpartum care center business generated revenue of 387 million yuan, a 25.3% increase, driven by an increase in the number of centers and improved performance of existing centers [2] - Home care services achieved revenue of 39 million yuan, up 41.7%, while food product revenue was 24 million yuan, a 10.5% increase [2] Strategic Development - Since 2018, the company has pursued a multi-brand and globalization strategy, creating a pyramid matrix with flagship brand "Saint Bella" targeting ultra-high-net-worth individuals, "Little Bella" aimed at young middle-class consumers, and "Ai Yu" focusing on psychological healing needs [3] - The company has expanded its service offerings to cover a full cycle from pregnancy to early childhood, enhancing customer loyalty and lifecycle value [3] Market Trends - The family care industry is projected to grow to 805.3 billion yuan by 2025, with postpartum care and recovery expected to reach 79.3 billion yuan, reflecting a compound annual growth rate of 20.4% from 2025 to 2030 [4] - The growth is driven by supportive policies and changing consumer behaviors among new-generation women [4] Competitive Landscape - The focus for future competition will be on the ability to convert detailed postpartum care services into modular solutions for elderly care, while avoiding dilution of capabilities during business expansion [5] - The company plans to deepen its core market presence, enhance its brand, and develop top-tier nursing talent while upgrading its digital infrastructure [5]